Biosimulation company Certara said on Thursday that the international registry of healthcare workers will collect information on risk factors for developing COVID-19 as well as using preventative therapies in protecting the healthcare workers during today's global health crisis and for future outbreaks, under The International Registry of Healthcare Workers Exposed to COVID-19 (UNITY Global).
Under UNITY Global, Certara will enable prevention policies based on real-world data collected from 10,000 healthcare workers in low- and middle- income countries. The initiative was funded by the COVID-19 Therapeutics Accelerator. The primary objective is to assess the association between the use of preventive treatments and the occurrence of SARS-CoV-2 infection in healthcare workers.
The company stated the registry first launched in Pakistan on 3 August 2020 and will enroll 10,000 healthcare workers. Additional countries preparing for launch of the registry include South Africa, Nigeria, Kenya, Uganda, Senegal, Zambia and Zimbabwe. The registry collects information on a weekly basis from enrollees across a 12-week period. The registry will record SARS-CoV-2 antibody test results.
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Lilly declares Q3 2026 dividend
Abbott declares quarterly dividend of USD0.63 per share
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share
Convatec launches co-branded eakin freeseal ostomy seal in North America